Bausch Health Companies Inc. Operating Income Loss

• Bausch Health Companies Inc. showed an increase of +17.3% in Operating Income Loss from 2024 to 2025.
• This data is from Bausch Health Companies Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), Bausch Health Companies Inc.'s Operating Income Loss has grown by 1,360.8%.
• Historical annual values: Fiscal year 2025: $1.81 billion | Fiscal year 2024: $1.55 billion | Fiscal year 2023: $963.00 million | Fiscal year 2022: $454.00 million | Fiscal year 2021: $450.00 million | Fiscal year 2020: $676.00 million | Fiscal year 2019: -$203.00 million | Fiscal year 2018: -$2.38 billion | Fiscal year 2017: $102.00 million | Fiscal year 2016: -$566.00 million | Fiscal year 2015: $1.53 billion | Fiscal year 2014: $2.00 billion | Fiscal year 2013: -$409.50 million | Fiscal year 2012: $79.70 million | Fiscal year 2011: $299.96 million | Fiscal year 2010: -$110.09 million | Fiscal year 2009: $181.15 million | Fiscal year 2008: $124.11 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026